[Effect of Pterostilbene Regulating Nuclear Factor E2-Related Factor 2 on Apoptosis of Colon Cancer Cells ].

Objective To investigate the effects of pterostilbene on human colon cancer LoVo cells and study the regulatory mechanism of nuclear factor E2-related factor 2 (Nrf2) in the process of pterostilbene acting on LoVo cells. Methods LoVo cells were treated with different concentrations (5,10,20,40,60,80,100 μmol/L) of pterostilbene.Cell viability,migration,invasion,and apoptosis were examined by CCK-8,scratch,Transwell,and TUNEL assays,respectively.The mitochondrial membrane potential was measured by the mitochondrial membrane potential assay kit with JC-1.The reactive oxygen species level was measured by 2',7'-dichlorofluorescein diacetate.The protein levels of Nrf2,phosphorylated Nrf2,heme oxygenase 1,and apoptotic proteins (Bcl2 and Bax) were determined by Western blotting.In addition,cell viability,Nrf2 expression,and apoptosis rate were determined after co-application of the Nrf2-specific agonist sulforaphane. Results Compared with the control group,40,60,80,100 μmol/L pterostilbene reduced the viability of LoVo cells (=0.014,<0.001,<0.001,<0.001).Pterostilbene at 5,10,20 μmol/L did not show effects on cell viability but inhibited cell migration (=0.008,<0.001,<0.001) and invasion (all <0.001).Pterostilbene at 40,60,80 μmol/L increased apoptosis (=0.014,<0.001,<0.001),promoted mitochondrial membrane potential depolarization (=0.026,<0.001,<0.001) and reactive oxygen species accumulation (all <0.001),and down-regulated the expression of phosphorylated Nrf2 (=0.030,<0.001,<0.001),heme oxygenase 1 (=0.015,<0.001,<0.001),and Bcl2 (=0.039,<0.001,<0.001) in LoVo cells.Pterostilbene at 60,80 μmol/L down-regulated Nrf2 expression (=0.001,<0.001) and up-regulated Bax expression (both <0.001).The application of sulforaphane reversed the effects of pterostilbene on cell viability (<0.001),apoptosis (<0.001),and Nrf2 expression (=0.022). Conclusion Pterostilbene is a compound that can effectively inhibit colon cancer cells by inhibiting the Nrf2 pathway.